Broadview Advisors LLC increased its position in Select Medical Holdings (NYSE:SEM) by 24.8% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 530,080 shares of the health services provider’s stock after acquiring an additional 105,325 shares during the period. Select Medical comprises about 1.5% of Broadview Advisors LLC’s investment portfolio, making the stock its 23rd biggest holding. Broadview Advisors LLC’s holdings in Select Medical were worth $9,144,000 at the end of the most recent reporting period.
Other large investors also recently added to or reduced their stakes in the company. Elkfork Partners LLC bought a new stake in Select Medical during the fourth quarter valued at about $181,000. Quantbot Technologies LP bought a new stake in Select Medical during the first quarter valued at about $215,000. Xact Kapitalforvaltning AB bought a new stake in Select Medical during the fourth quarter valued at about $223,000. SG Americas Securities LLC grew its holdings in Select Medical by 76.7% during the first quarter. SG Americas Securities LLC now owns 16,762 shares of the health services provider’s stock valued at $289,000 after purchasing an additional 7,276 shares during the period. Finally, Stevens Capital Management LP bought a new stake in Select Medical during the first quarter valued at about $306,000. 76.93% of the stock is owned by institutional investors and hedge funds.
NYSE SEM opened at $18.25 on Monday. The stock has a market capitalization of $2.45 billion, a PE ratio of 18.81, a price-to-earnings-growth ratio of 1.24 and a beta of 1.30. The company has a debt-to-equity ratio of 3.60, a current ratio of 1.66 and a quick ratio of 1.66. Select Medical Holdings has a twelve month low of $13.30 and a twelve month high of $19.77.
Select Medical (NYSE:SEM) last released its quarterly earnings data on Thursday, May 3rd. The health services provider reported $0.29 earnings per share for the quarter, topping analysts’ consensus estimates of $0.26 by $0.03. The firm had revenue of $1.25 billion during the quarter, compared to analyst estimates of $1.23 billion. Select Medical had a return on equity of 15.19% and a net margin of 4.23%. The business’s quarterly revenue was up 14.7% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.21 earnings per share. equities research analysts predict that Select Medical Holdings will post 1.05 earnings per share for the current fiscal year.
Several research firms have issued reports on SEM. Zacks Investment Research lowered Select Medical from a “hold” rating to a “sell” rating in a report on Friday, May 11th. ValuEngine lowered Select Medical from a “strong-buy” rating to a “buy” rating in a report on Monday, May 7th. Robert W. Baird reissued a “buy” rating and set a $26.00 price target on shares of Select Medical in a report on Friday, February 23rd. TheStreet lowered Select Medical from a “b-” rating to a “c+” rating in a report on Friday, February 2nd. Finally, JMP Securities raised Select Medical from an “underperform” rating to a “market perform” rating and set a $12.00 price target for the company in a report on Tuesday, February 27th. One analyst has rated the stock with a sell rating, three have given a hold rating and six have assigned a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus target price of $20.63.
In other news, Chairman Robert A. Ortenzio sold 148,213 shares of the company’s stock in a transaction dated Wednesday, May 23rd. The stock was sold at an average price of $18.55, for a total value of $2,749,351.15. Following the completion of the transaction, the chairman now owns 7,086,480 shares of the company’s stock, valued at $131,454,204. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, VP Robert G. Breighner, Jr. sold 3,428 shares of the company’s stock in a transaction dated Tuesday, May 8th. The stock was sold at an average price of $18.03, for a total value of $61,806.84. Following the completion of the transaction, the vice president now directly owns 31,589 shares of the company’s stock, valued at approximately $569,549.67. The disclosure for this sale can be found here. In the last ninety days, insiders sold 384,268 shares of company stock valued at $7,124,700. Corporate insiders own 19.86% of the company’s stock.
About Select Medical
Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates acute care hospitals (LTCHs), inpatient rehabilitation facilities (IRFs), outpatient rehabilitation clinics, and occupational medicine centers in the United States. The company operates through four segments: Long Term Acute Care, Inpatient Rehabilitation, Outpatient Rehabilitation, and Concentra.
Want to see what other hedge funds are holding SEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Select Medical Holdings (NYSE:SEM).
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.